About 90% of MSI colorectal tumors exhibit inactivating frameshift mutations in a polyadenine (A10) tract in exon 3 of Transforming Growth Factor Beta Receptor Type 2 (TGFBR2) gene [13,14]. Here, TGFBR2 is linked to colorectal neoplasm.